Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Quantum Genesis AI (QTZM) Operating Expenses (2016 - 2026)

Quantumzyme's Operating Expenses history spans 7 years, with the latest figure at $1382.0 for Q1 2026.

  • For Q1 2026, Operating Expenses fell 94.37% year-over-year to $1382.0; the TTM value through Jan 2026 reached $40578.0, down 57.6%, while the annual FY2025 figure was $180537.0, 10.36% up from the prior year.
  • Operating Expenses reached $1382.0 in Q1 2026 per QTZM's latest filing, down from $39196.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $60934.0 in Q4 2024 to a low of $1382.0 in Q1 2026.
  • Average Operating Expenses over 3 years is $31511.5, with a median of $31865.0 recorded in 2025.
  • Peak YoY movement for Operating Expenses: tumbled 35.67% in 2025, then tumbled 94.37% in 2026.
  • A 3-year view of Operating Expenses shows it stood at $60934.0 in 2024, then crashed by 35.67% to $39196.0 in 2025, then crashed by 96.47% to $1382.0 in 2026.
  • Per Business Quant, the three most recent readings for QTZM's Operating Expenses are $1382.0 (Q1 2026), $39196.0 (Q4 2025), and $24534.0 (Q1 2025).